Current Medical Research and Opinion

Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States
pp. 2305-2312(8)
Authors: Sun, Shawn X.; Liu, Gordon G.; Christensen, Dale B.; Fu, Alex Z.

A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA)
pp. 2313-2323(11)
Authors: Wolf, Jürgen; Janssen, Firmin; Lublin, Henrik; Salokangas, Raimo K.R.; Allain, Hervé; Smeraldi, Enrico; Bernardo, Miguel; Millar, Helen; Pans, Miranda; Adelbrecht, Christine; Laughton, Jim; Werner, Christian; Maier, Wolfgang

Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery
pp. 2325-2331(7)
Authors: Raizman, Michael B.; Donnenfeld, Eric D.; Weinstein, Arthur J.

Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone
pp. 2333-2345(13)
Authors: Ward, Alexandra; Bozkaya, Duygu; Fleischmann, Jochen; Dubois, Dominique; Sabatowski, Rainer; Caro, J. Jaime

Darifenacin treatment of patients ≥ 65 years with overactive bladder: results of a randomized, controlled, 12-week trial
pp. 2347-2358(12)
Authors: Chapple, C.; DuBeau, C.; Ebinger, U.; Rekeda, L.; Viegas, A.

Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database
pp. 2359-2368(10)
Authors: Whyte, Ian M.; Francis, Barbara; Dawson, Andrew H.

Methodological considerations in using claims databases to evaluate persistence with bisphosphonates for osteoporosis
pp. 2369-2377(9)
Authors: Cramer, Joyce A.; Silverman, Stuart L.; Gold, Deborah T.

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis
pp. 2379-2386(8)
Authors: Busse, William W.; Massanari, Marc; Kianifard, Farid; Geba, Gregory P.

Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma
pp. 2387-2394(8)
Authors: Knox, A.; Langan, J.; Martinot, J-B.; Gruss, C.; Häfner, D.

Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension
pp. 2395-2404(10)
Authors: Morrison, Alan; Ramey, Dena Rosen; van Adelsberg, Janet; Watson, Douglas J.

Inhalation devices for long-acting β₂-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD
pp. 2405-2413(9)
Authors: Molimard, Mathieu; Till, Denise; Stenglein, Stephan; Singh, Dilraj; Krummen, Markus

A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections
pp. 2415-2422(8)
Authors: Albrecht, Uwe; Goos, Karl-Heinz; Schneider, Berthold

A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1
pp. 2423-2431(9)
Authors: Emberlin, J.C.; Lewis, R.A.

Use of almotriptan in triptan-experienced and triptan-naïve patients
pp. 2433-2440(8)
Authors: Pascual, Julio; Diener, Hans-Christoph

Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability
pp. 2441-2452(12)
Author: Bernstein, Jonathan A.

Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data
pp. 2453-2460(8)
Authors: Shabsigh, Ridwan; Duval, Sue; Shah, Manan; Regan, Timothy S.; Juhasz, Marta; Veltry, Lauren G.

Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy
pp. 2461-2465(5)
Authors: Baumann, Robert J.; Fakhoury, Toufic A.; Kustra, Robert P.; Vuong, Alain; Hammer, Anne E.; Messenheimer, John A.

Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?
pp. 2467-2476(10)
Authors: Kanavos, Panos; Taylor, David

Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs
pp. 2477-2483(7)
Authors: Bonasia, Phil; Cook, Carrie; Cheng, Yufei; Ong, Shaowei

Patient and caregiver outcomes after 6 ± 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study
pp. 2485-2501(17)
Authors: Mets, Tony; Vandewoude, Maurits; Jacquy, Jean; Deblander, Anne; MacDonald, Karen; Sloesen, Anne; Abraham, Ivo; FExT Study Group,

Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study
pp. 2503-2506(4)
Authors: Cadario, Gianni; Galluccio, Antonia G.; Pezza, Michele; Appino, Antonella; Milani, Massimo; Pecora, Silvia; Mastrandrea, Fulvio

Patient-controlled analgesia: patient and nurse satisfaction with intravenous delivery systems and expected satisfaction with transdermal delivery systems
pp. 2507-2516(10)
Authors: Gan, Tong J.; Gordon, Debra B.; Bolge, Susan C.; Allen, Jennifer Gano

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates
pp. 2517-2529(13)
Authors: Earnshaw, S.R.; Graham, C.N.; Ettinger, B.; Amonkar, M.M.; Lynch, N.O.; Middelhoven, H.

Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain
pp. 2531-2542(12)
Authors: Pascual, Maria Luz G.; Fleming, Rosa Rosanna B.; Gana, Theophilus J.; Vorsanger, Gary J.

Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial
pp. 2543-2549(7)
Authors: Allgulander, C.; Jørgensen, T.; Wade, A.; François, C.; Despiegel, N.; Auquier, P.; Toumi, M.

Reviewing CATIE for clinicians: balancing benefit and risk using evidence-based medicine tools
pp. 2551-2557(7)
Authors: Karagianis, Jamie; Rosenbluth, Michael; Tohen, Mauricio; Ascher-Svanum, Haya; Treuer, Tamas; Silva de Lima, Mauricio; Citrome, Leslie

Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant
pp. 2559-2565(7)
Authors: Diemunsch, Pierre; Apfel, Christian; Gan, Tong J.; Candiotti, Keith; Philip, Beverly K.; Chelly, Jacques; Carides, Alexandra D.; Evans, Judith K.; Ho, Tony W.; Reiss, Theodore

How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs
pp. 2567-2576(10)
Authors: Valuck, Robert J.; Morrato, Elaine H.; Dodd, Sheri; Oderda, Gary; Haxby, Dean G.; Allen, Richard; Medicaid Pharmacotherapy Research Consortium,

Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate
pp. 2577-2583(7)
Authors: Shah, P.J.R.; Dinsmore, W.; Oakes, R.A.; Hackett, Geoff

Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia
pp. 2585-2596(12)
Authors: Rodríguez, M.J.; Díaz, S.; Veral-Lonch, M.; Dukes, E.; Rejas, J.

Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes
pp. 2597-2605(9)
Authors: Wade, Alan G.; Ford, Ian; Crawford, Gordon; McMahon, Alex D.; Nir, Tali; Laudon, Moshe; Zisapel, Nava